As essential clinicopathological criteria to be assessed in the appropriate and individualized treatment of lung NETs, it validates the value of age, histotype, stage, lymph node status, Ki-67 index, mitotic count, and presence of functional syndromes. The gene discussed is MKI67; the disease is lung neuroendocrine neoplasm.